Surveillance of Fungal Infections During Construction Activity
NCT ID: NCT00473252
Last Updated: 2011-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
340 participants
OBSERVATIONAL
2006-05-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, the question of a causal relation between construction activities and infections has never been addressed systematically and prospectively.
To answer this question, we will monitor our immunosuppressed patients' health status, as well as fine dust and aspergillus spore contents in the air during a three year construction activity period in our hospital.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Influenza RelAted Invasive Aspergillosis
NCT04172610
Fungal Surveillance in Bangladesh
NCT06103331
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis
NCT00923832
Systemic Fungal Infections in ICU Patients
NCT03292224
Perception and Prevalence of Fungal Infections in Berlin - Brandenburg
NCT01393002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemodialysis patients
No interventions assigned to this group
Renal transplant patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic hemodialysis treatment
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Nephrology and Hypertension, Inselspital, University Hospital Bern
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Pasch, MD
Role: STUDY_DIRECTOR
University of Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. Nephrology & Hypertension, Univ. Hospital Bern
Bern, Canton of Bern, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BE003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.